Literature DB >> 2284204

FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence.

D H Malin1, J R Lake, M V Hammond, D E Fowler, R B Rogillio, S L Brown, J L Sims, B M Leecraft, H Y Yang.   

Abstract

Yang et al. have isolated from bovine brain an octapeptide, FLFQPQRF-NH2 (F-8-F-NH2), with certain antiopiate properties. Malin et al. previously found that ICV injection of this peptide could precipitate an opiate abstinence syndrome in dependent rats. RIA revealed significantly higher levels of F-8-F-NH2 immunoreactivity in CSF withdrawn from the cisterna magna of morphine-dependent rats as opposed to CSF withdrawn from sham-implanted controls. ICV infusion of IgG from antiserum against F-8-F-NH2 significantly reduced the number of abstinence signs subsequently precipitated by naloxone in morphine-dependent rats.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2284204     DOI： 10.1016/0196-9781(90)90018-z

Source DB:  PubMed          Journal:  Peptides        ISSN： 0196-9781            Impact factor:   3.750


  10 in total

1.  Heterologous expression of the invertebrate FMRFamide-gated sodium channel as a mechanism to selectively activate mammalian neurons.

Authors:  S M Schanuel; K A Bell; S C Henderson; A R McQuiston
Journal:  Neuroscience       Date:  2008-06-10       Impact factor: 3.590

2.  Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

Authors:  K Elhabazi; J M Trigo; C Mollereau; L Moulédous; J-M Zajac; F Bihel; M Schmitt; J J Bourguignon; H Meziane; B Petit-demoulière; F Bockel; R Maldonado; F Simonin
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

3.  RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

Authors:  Frédéric Simonin; Martine Schmitt; Jean-Paul Laulin; Emilie Laboureyras; Jack H Jhamandas; David MacTavish; Audrey Matifas; Catherine Mollereau; Patrick Laurent; Marc Parmentier; Brigitte L Kieffer; Jean-Jacques Bourguignon; Guy Simonnet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

4.  Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats.

Authors:  K Lutfy; S M Hossain; I Khaliq; N T Maidment
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Naloxone precipitates nicotine abstinence syndrome in the rat.

Authors:  D H Malin; J R Lake; V A Carter; J S Cunningham; O B Wilson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.

Authors:  C Gouardères; K Jhamandas; M Sutak; J M Zajac
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?

Authors:  Laura Micheli; Elena Lucarini; Francesca Corti; Roberto Ciccocioppo; Girolamo Calò; Anna Rizzi; Carla Ghelardini; Lorenzo Di Cesare Mannelli
Journal:  Eur J Pharmacol       Date:  2018-01-31       Impact factor: 4.432

Review 8.  Involvement of Mammalian RF-Amide Peptides and Their Receptors in the Modulation of Nociception in Rodents.

Authors:  Safia Ayachi; Frédéric Simonin
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-02       Impact factor: 5.555

9.  Intracerebroventricular Neuropeptide FF Diminishes the Number of Apneas and Cardiovascular Effects Produced by Opioid Receptors' Activation.

Authors:  Piotr Wojciechowski; Kryspin Andrzejewski; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 10.  Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.

Authors:  Ewa Gibula-Tarlowska; Jolanta H Kotlinska
Journal:  Biomolecules       Date:  2020-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.